Founded in 2005, Myoscience is an innovation-driven medical technology company located in Fremont, California. In 2014 we received FDA clearance to market our technology for treating peripheral nerves with cryoneurolysis to block pain. The iovera° technology is the only non-opioid therapy in the market that utilizes cryoneurolysis to alleviate pain by disrupting pain signals from being transmitted to the brain.
We are dedicated to establishing our proprietary technology as the standard of care for several conditions involving peripheral nerves.
We are equally dedicated to creating a work environment that produces innovative thinking – and proud that we’re putting our name on a product that we ourselves would use.
We are driven to improve patients’ lives by alleviating their chronic and acute pain without opioids. We strive to make our proprietary technology the standard of care and the primary modality in treating pain.
We are dedicated to improving patients’ lives by providing safe and innovative medical technologies that produce clinically proven drug-free pain treatments. We continuously strive to improve the quality and technology of our products, enhancing both patient satisfaction and customer experience.
Board of Directors
Additional European investors introduced by American Equities Overseas Inc.